4
Changes in Ownership
BIOGEN INC. Filed Acc 0001127602-21-007000
Options or other derivatives
- EVP, Research & Development acquired 14,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sandrock Alfred · EVP, Research & Development
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-18 | Grant or award : show line 1 in the form Restricted Stock Unit | +14,500 | 14,500 | D |
Loading xslF345X03/form4.xml…